{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:32:39Z","timestamp":1766853159480,"version":"3.48.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-024-10152-0","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T20:42:21Z","timestamp":1735159341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated serum neprilysin levels in patients with chronic hepatitis C and metabolic dysfunction-associated steatotic liver disease: hepatic oxidative stress as an underlying mechanism"],"prefix":"10.1007","volume":"52","author":[{"given":"Kensuke","family":"Kitsugi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Chida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maho","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenao","family":"Noritake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"10152_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama Y, Brenner DA (2017) Liver inflammation and fibrosis. J Clin Invest 127:55\u201364. https:\/\/doi.org\/10.1172\/JCI88881","journal-title":"J Clin Invest"},{"key":"10152_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jceh.2017.09.004","volume":"7","author":"A Naim","year":"2017","unstructured":"Naim A, Pan Q, Baig MS (2017) Matrix metalloproteinases (MMPs) in liver diseases. J Clin Exp Hepatol 7:367\u2013372. https:\/\/doi.org\/10.1016\/j.jceh.2017.09.004","journal-title":"J Clin Exp Hepatol"},{"key":"10152_CR3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1515\/hsz-2021-0149","volume":"402","author":"M Al-Salihi","year":"2021","unstructured":"Al-Salihi M, Bornikoel A, Zhuang Y et al (2021) The role of ADAM17 during liver damage. Biol Chem 402:1115\u20131128. https:\/\/doi.org\/10.1515\/hsz-2021-0149","journal-title":"Biol Chem"},{"key":"10152_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jacc.2016.04.060","volume":"68","author":"A Bayes -Genis","year":"2016","unstructured":"Bayes -Genis A, Antoni, Barallat J, Richards AM (2016) A test in context: neprilysin. J Am Coll Cardiol 68:639\u2013653. https:\/\/doi.org\/10.1016\/j.jacc.2016.04.060","journal-title":"J Am Coll Cardiol"},{"key":"10152_CR5","first-page":"210","volume":"58","author":"P Ronco","year":"1988","unstructured":"Ronco P, Pollard H, Galceran M et al (1988) Distribution of enkephalinase (membrane metalloendopeptidase, E.C. 3.4.24.11) in rat organs. Detection using a monoclonal antibody. Lab Investig J Tech Methods Pathol 58:210\u2013217","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"10152_CR6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJV McMurray","year":"2014","unstructured":"McMurray JJV, Packer M, Desai AS et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993\u20131004. https:\/\/doi.org\/10.1056\/NEJMoa1409077","journal-title":"N Engl J Med"},{"key":"10152_CR7","doi-asserted-by":"publisher","first-page":"112059","DOI":"10.1016\/j.celrep.2023.112059","volume":"42","author":"C Ortiz","year":"2023","unstructured":"Ortiz C, Klein S, Reul WH et al (2023) Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1. Cell Rep 42:112059. https:\/\/doi.org\/10.1016\/j.celrep.2023.112059","journal-title":"Cell Rep"},{"key":"10152_CR8","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/biomedicines11051295","volume":"11","author":"J Suzuki","year":"2023","unstructured":"Suzuki J, Kaji K, Nishimura N et al (2023) A combination of an angiotensin II receptor and a neprilysin inhibitor attenuates liver fibrosis by preventing hepatic stellate cell activation. Biomedicines 11:1295. https:\/\/doi.org\/10.3390\/biomedicines11051295","journal-title":"Biomedicines"},{"key":"10152_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/pharmaceutics12040320","volume":"12","author":"S-J Hsu","year":"2020","unstructured":"Hsu S-J, Huang H-C, Chuang C-L et al (2020) Dual angiotensin receptor and neprilysin inhibitor ameliorates portal hypertension in portal hypertensive rats. Pharmaceutics 12:320. https:\/\/doi.org\/10.3390\/pharmaceutics12040320","journal-title":"Pharmaceutics"},{"key":"10152_CR10","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1177\/1535370219861283","volume":"244","author":"Q Ge","year":"2019","unstructured":"Ge Q, Zhao L, Ren X-M et al (2019) LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis. Exp Biol Med Maywood NJ 244:1028\u20131039. https:\/\/doi.org\/10.1177\/1535370219861283","journal-title":"Exp Biol Med Maywood NJ"},{"key":"10152_CR11","doi-asserted-by":"publisher","first-page":"108056","DOI":"10.1016\/j.jdiacomp.2021.108056","volume":"36","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhou Y, Ma R (2022) Potential effects and application prospect of angiotensin receptor-neprilysin inhibitor in diabetic kidney disease. J Diabetes Complications 36:108056. https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.108056","journal-title":"J Diabetes Complications"},{"key":"10152_CR12","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.7150\/ijms.49373","volume":"17","author":"F Alqahtani","year":"2020","unstructured":"Alqahtani F, Mohany M, Alasmari AF et al (2020) Angiotensin II receptor neprilysin inhibitor (LCZ696) compared to valsartan attenuates hepatotoxicity in STZ-induced hyperglycemic rats. Int J Med Sci 17:3098\u20133106. https:\/\/doi.org\/10.7150\/ijms.49373","journal-title":"Int J Med Sci"},{"key":"10152_CR13","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/17474124.2021.1949289","volume":"15","author":"S Seen","year":"2021","unstructured":"Seen S (2021) Chronic liver disease and oxidative stress - a narrative review. Expert Rev Gastroenterol Hepatol 15:1021\u20131035. https:\/\/doi.org\/10.1080\/17474124.2021.1949289","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10152_CR14","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatol Baltim Md 78:1966\u20131986. https:\/\/doi.org\/10.1097\/HEP.0000000000000520","journal-title":"Hepatol Baltim Md"},{"key":"10152_CR15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/hep.23314","volume":"51","author":"C S\u00f6derberg","year":"2010","unstructured":"S\u00f6derberg C, St\u00e5l P, Askling J et al (2010) Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatol Baltim Md 51:595\u2013602. https:\/\/doi.org\/10.1002\/hep.23314","journal-title":"Hepatol Baltim Md"},{"key":"10152_CR16","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association. Hepatol Baltim Md 55:2005\u20132023. https:\/\/doi.org\/10.1002\/hep.25762","journal-title":"Hepatol Baltim Md"},{"key":"10152_CR17","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1148\/radiol.2016160209","volume":"281","author":"AT Trout","year":"2016","unstructured":"Trout AT, Serai S, Mahley AD et al (2016) Liver stiffness measurements with MR elastography: agreement and repeatability across imaging systems, field strengths, and pulse sequences. Radiology 281:793\u2013804. https:\/\/doi.org\/10.1148\/radiol.2016160209","journal-title":"Radiology"},{"key":"10152_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0928-4346(96)00325-8","volume":"6","author":"F Ichida","year":"1996","unstructured":"Ichida F, Tsuji T, Omata M et al (1996) New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 6:112\u2013119. https:\/\/doi.org\/10.1016\/S0928-4346(96)00325-8","journal-title":"Int Hepatol Commun"},{"key":"10152_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods San Diego Calif 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods San Diego Calif"},{"key":"10152_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software EZR for medical statistics. Bone Marrow Transpl 48:452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transpl"},{"key":"10152_CR21","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1038\/s41598-022-08955-x","volume":"12","author":"K Thanapirom","year":"2022","unstructured":"Thanapirom K, Suksawatamnuay S, Tanpowpong N et al (2022) Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study. Sci Rep 12:4913. https:\/\/doi.org\/10.1038\/s41598-022-08955-x","journal-title":"Sci Rep"},{"key":"10152_CR22","doi-asserted-by":"publisher","first-page":"e015071","DOI":"10.1161\/JAHA.119.015071","volume":"9","author":"S Prausm\u00fcller","year":"2020","unstructured":"Prausm\u00fcller S, Arfsten H, Spinka G et al (2020) Plasma neprilysin displays no relevant association with neurohumoral activation in chronic HFrEF. J Am Heart Assoc 9:e015071. https:\/\/doi.org\/10.1161\/JAHA.119.015071","journal-title":"J Am Heart Assoc"},{"key":"10152_CR23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jacc.2014.11.048","volume":"65","author":"A Bay\u00e9s-Gen\u00eds","year":"2015","unstructured":"Bay\u00e9s-Gen\u00eds A, Barallat J, Gal\u00e1n A et al (2015) Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients. J Am Coll Cardiol 65:657\u2013665. https:\/\/doi.org\/10.1016\/j.jacc.2014.11.048","journal-title":"J Am Coll Cardiol"},{"key":"10152_CR24","doi-asserted-by":"publisher","first-page":"e005712","DOI":"10.1161\/JAHA.117.005712","volume":"6","author":"J N\u00fa\u00f1ez","year":"2017","unstructured":"N\u00fa\u00f1ez J, N\u00fa\u00f1ez E, Barallat J et al (2017) Serum neprilysin and recurrent admissions in patients with heart failure. J Am Heart Assoc 6:e005712. https:\/\/doi.org\/10.1161\/JAHA.117.005712","journal-title":"J Am Heart Assoc"},{"key":"10152_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4183\/aeb.2022.35","volume":"18","author":"OO Gul","year":"2022","unstructured":"Gul OO, Sisman P, Cander S et al (2022) Plasma neprilysin levels in patients with polycystic ovary syndrome. Acta Endocrinol Buchar Rom 2005 18:35\u201339. https:\/\/doi.org\/10.4183\/aeb.2022.35","journal-title":"Acta Endocrinol Buchar Rom 2005"},{"key":"10152_CR26","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/ehf2.13787","volume":"9","author":"M Lenz","year":"2022","unstructured":"Lenz M, Krychtiuk KA, Brekalo M et al (2022) Soluble neprilysin and survival in critically ill patients. ESC Heart Fail 9:1160\u20131166. https:\/\/doi.org\/10.1002\/ehf2.13787","journal-title":"ESC Heart Fail"},{"key":"10152_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0024-3205(89)90287-7","volume":"45","author":"M Deschodt-Lanckman","year":"1989","unstructured":"Deschodt-Lanckman M, Michaux F, De Prez E et al (1989) Increased serum levels of endopeptidase 24.11 (\u2018enkephalinase\u2019) in patients with end-stage renal failure. Life Sci 45:133\u2013141. https:\/\/doi.org\/10.1016\/0024-3205(89)90287-7","journal-title":"Life Sci"},{"key":"10152_CR28","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1093\/eurheartj\/ehy454","volume":"39","author":"H Takahama","year":"2018","unstructured":"Takahama H, Minamino N, Izumi C (2018) Plasma soluble neprilysin levels are unchanged during recovery after decompensation of heart failure: a matter of the magnitude of the changes in systemic haemodynamics? Eur Heart J 39:3472\u20133473. https:\/\/doi.org\/10.1093\/eurheartj\/ehy454","journal-title":"Eur Heart J"},{"key":"10152_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jchf.2019.07.005","volume":"8","author":"MA Lyle","year":"2020","unstructured":"Lyle MA, Iyer SR, Redfield MM et al (2020) Circulating neprilysin in patients with heart failure and preserved ejection fraction. JACC Heart Fail 8:70\u201380. https:\/\/doi.org\/10.1016\/j.jchf.2019.07.005","journal-title":"JACC Heart Fail"},{"key":"10152_CR30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.21037\/atm.2016.12.27","volume":"4","author":"G Ndrepepa","year":"2016","unstructured":"Ndrepepa G, Kastrati A (2016) Gamma-Glutamyl transferase and cardiovascular disease. Ann Transl Med 4:481. https:\/\/doi.org\/10.21037\/atm.2016.12.27","journal-title":"Ann Transl Med"},{"key":"10152_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/JIR.S148911","volume":"11","author":"C Pouvreau","year":"2018","unstructured":"Pouvreau C, Dayre A, Butkowski EG et al (2018) Inflammation and oxidative stress markers in diabetes and hypertension. J Inflamm Res 11:61\u201368. https:\/\/doi.org\/10.2147\/JIR.S148911","journal-title":"J Inflamm Res"},{"key":"10152_CR32","unstructured":"Increasing oxidative stress with progressive hyperlipidemia in human relation between malondialdehyde and atherogenic index - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/19015749\/. Accessed 21 May 2024"},{"key":"10152_CR33","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00125-016-4172-4","volume":"60","author":"JR Willard","year":"2017","unstructured":"Willard JR, Barrow BM, Zraika S (2017) Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels. Diabetologia 60:701\u2013708. https:\/\/doi.org\/10.1007\/s00125-016-4172-4","journal-title":"Diabetologia"},{"key":"10152_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/nu15030687","volume":"15","author":"D Clayton-Chubb","year":"2023","unstructured":"Clayton-Chubb D, Kemp W, Majeed A et al (2023) Understanding NAFLD: from case identification to interventions, outcomes, and future perspectives. Nutrients 15:687. https:\/\/doi.org\/10.3390\/nu15030687","journal-title":"Nutrients"},{"key":"10152_CR35","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/ijo.2010.227","volume":"35","author":"KF Standeven","year":"2011","unstructured":"Standeven KF, Hess K, Carter AM et al (2011) Neprilysin, obesity and the metabolic syndrome. Int J Obes 35:1031\u20131040. https:\/\/doi.org\/10.1038\/ijo.2010.227","journal-title":"Int J Obes"},{"key":"10152_CR36","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3748\/wjg.v22.i4.1461","volume":"22","author":"M-L Chang","year":"2016","unstructured":"Chang M-L (2016) Metabolic alterations and hepatitis C: from bench to bedside. World J Gastroenterol 22:1461\u20131476. https:\/\/doi.org\/10.3748\/wjg.v22.i4.1461","journal-title":"World J Gastroenterol"},{"key":"10152_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/biomedicines11020271","volume":"11","author":"W Elgretli","year":"2023","unstructured":"Elgretli W, Chen T, Kronfli N, Sebastiani G (2023) Hepatitis C virus-lipid interplay: pathogenesis and clinical impact. Biomedicines 11:271. https:\/\/doi.org\/10.3390\/biomedicines11020271","journal-title":"Biomedicines"},{"key":"10152_CR38","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1165\/rcmb.2009-0169TR","volume":"41","author":"H Zhang","year":"2009","unstructured":"Zhang H, Forman HJ (2009) Redox regulation of gamma-glutamyl transpeptidase. Am J Respir Cell Mol Biol 41:509\u2013515. https:\/\/doi.org\/10.1165\/rcmb.2009-0169TR","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10152_CR39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/10715760410001694026","volume":"38","author":"D-H Lee","year":"2004","unstructured":"Lee D-H, Blomhoff R, Jacobs DR (2004) Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 38:535\u2013539. https:\/\/doi.org\/10.1080\/10715760410001694026","journal-title":"Free Radic Res"},{"key":"10152_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5455\/medarh.2017.72.112-115","volume":"72","author":"V Coku","year":"2018","unstructured":"Coku V, Shkembi X (2018) Serum Gamma-glutamyltransferase and obesity: is there a link? Med Arch Sarajevo Bosnia Herzeg 72:112\u2013115. https:\/\/doi.org\/10.5455\/medarh.2017.72.112-115","journal-title":"Med Arch Sarajevo Bosnia Herzeg"},{"key":"10152_CR41","doi-asserted-by":"publisher","first-page":"7425628","DOI":"10.1155\/2016\/7425628","volume":"2016","author":"K Rebbani","year":"2016","unstructured":"Rebbani K, Tsukiyama-Kohara K (2016) HCV-Induced oxidative stress: battlefield-winning strategy. Oxid Med Cell Longev 2016:7425628. https:\/\/doi.org\/10.1155\/2016\/7425628","journal-title":"Oxid Med Cell Longev"},{"key":"10152_CR42","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1053\/gast.2002.36572","volume":"123","author":"AJ Sanyal","year":"2002","unstructured":"Sanyal AJ, American Gastroenterological Association (2002) AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123:1705\u20131725. https:\/\/doi.org\/10.1053\/gast.2002.36572","journal-title":"Gastroenterology"},{"key":"10152_CR43","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/hep.26203","volume":"57","author":"JE Everhart","year":"2013","unstructured":"Everhart JE, Wright EC (2013) Association of \u03b3-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV). Hepatol Baltim Md 57:1725\u20131733. https:\/\/doi.org\/10.1002\/hep.26203","journal-title":"Hepatol Baltim Md"},{"key":"10152_CR44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/ceh.2021.104466","volume":"7","author":"D Orzechowska","year":"2021","unstructured":"Orzechowska D, Klimowicz K, St\u0119pie\u0144 A et al (2021) Change in \u03b3-glutamyl transpeptidase activity as a useful tool in identifying a group of patients with elevated risk of hepatocellular carcinoma development after DAA treatment of chronic hepatitis C. Clin Exp Hepatol 7:93\u2013100. https:\/\/doi.org\/10.5114\/ceh.2021.104466","journal-title":"Clin Exp Hepatol"},{"key":"10152_CR45","doi-asserted-by":"publisher","first-page":"7087921","DOI":"10.1155\/2020\/7087921","volume":"2020","author":"S Ahmed","year":"2020","unstructured":"Ahmed S, Zahoor A, Ibrahim M et al (2020) Enhanced efficacy of direct-acting antivirals in Hepatitis C patients by coadministration of black cumin and ascorbate as antioxidant adjuvants. Oxid Med Cell Longev 2020:7087921. https:\/\/doi.org\/10.1155\/2020\/7087921","journal-title":"Oxid Med Cell Longev"},{"key":"10152_CR46","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3349\/ymj.2017.58.4.763","volume":"58","author":"D Yadav","year":"2017","unstructured":"Yadav D, Lee MY, Kim JY et al (2017) Combined effect of initial and longitudinal increases in \u03b3-Glutamyltransferase on Incident metabolic syndrome: ARIRANG study. Yonsei Med J 58:763\u2013769. https:\/\/doi.org\/10.3349\/ymj.2017.58.4.763","journal-title":"Yonsei Med J"},{"key":"10152_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3350\/kjhep.2011.17.1.27","volume":"17","author":"HJ Oh","year":"2011","unstructured":"Oh HJ, Kim TH, Sohn YW et al (2011) Association of serum alanine aminotransferase and \u03b3-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease. Korean J Hepatol 17:27\u201336. https:\/\/doi.org\/10.3350\/kjhep.2011.17.1.27","journal-title":"Korean J Hepatol"},{"key":"10152_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jceh.2012.10.009","volume":"3","author":"A Kumar","year":"2013","unstructured":"Kumar A, Sharma A, Duseja A et al (2013) Patients with nonalcoholic fatty liver Disease (NAFLD) have higher oxidative stress in comparison to chronic viral Hepatitis. J Clin Exp Hepatol 3:12\u201318. https:\/\/doi.org\/10.1016\/j.jceh.2012.10.009","journal-title":"J Clin Exp Hepatol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10152-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-10152-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10152-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:30:09Z","timestamp":1766853009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-10152-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10152"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-10152-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Hamamatsu University Hospital (approval number: 23\u2013355).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained by all participating patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}},{"value":"N\/A.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"81"}}